Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials

INTRODUCTION. For anticancer drug development, it is crucial that patients participate in early-phase clinical trials. The main aim of this study was to gain insight into the motivations and other variables influencing patients in their decision to participate in phase I oncology trials. MATERIALS A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: van der Biessen, Diane A.J., Cranendonk, Merlijn A., Schiavon, Gaia, van der Holt, Bronno, Wiemer, Erik A.C., Eskens, Ferry A.L.M., Verweij, Jaap, de Jonge, Maja J.A., Mathijssen, Ron H.J.
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2013
Matèries:
New Drug Development and Clinical Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607530/
https://ncbi.nlm.nih.gov/pubmed/23429738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0334
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars